Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Hemangiosarcoma 2Choriocarcinoma 2Carcinoma, Non-Small-Cell Lung 2Trophoblastic Tumor, Placental Site 1Solid Tumors 1Sarcoma 1Ovarian Neoplasms 1Glioblastoma 1Gestational Trophoblastic Disease 1Fallopian Tube Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Adult Solid Tumor 1

Interventions

Carboplatin 367Pemetrexed 308pembrolizumab 302Cisplatin 242Paclitaxel 230Docetaxel 199Gemcitabine 130Nivolumab 121Erlotinib Hydrochloride 114Bevacizumab 85osimertinib 78atezolizumab 65durvalumab 58Cetuximab 57130-nm albumin-bound paclitaxel 56Gefitinib 52Ipilimumab 46Afatinib 38Drug Therapy 33Cyclophosphamide 30Crizotinib 30Albumin-Bound Paclitaxel 30Vinorelbine 28cemiplimab 26tislelizumab 25avelumab 23icotinib 22Radiotherapy 22capmatinib 21Oxaliplatin 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Carcinoma, Non-Small-Cell Lung × carotuximab × Clear all
NCT03181308 2020-06-24

Study of Carotuximab (TRC105) Plus Nivolumab in Patients With Metastatic NSCLC

Tracon Pharmaceuticals Inc.

Phase 1 Completed
11 enrolled 11 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03780010 2019-10-28

Study of TRC105 + Paclitaxel/Carboplatin and Bevacizumab in Patients With NSCLC

Tracon Pharmaceuticals Inc.

Phase 1 Completed
15 enrolled 14 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡